SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Amgen (AMGN)

AMGN RSS Feed
Add AMGN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/23/2016 7:13:48 PM - Followers: 15 - Board type: Free - Posts Today: 0
This board is for fundamental and technical discussion about Amgen, AMGN.

Amgen Inc. (Amgen) is a global biotechnology company. It discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of supportive cancer care, nephrology, inflammation and oncology. In September 2006, Vectibix (panitumumab), Amgen's first oncology therapeutic, received the United States Food and Drug Administration approval and became commercially available in October 2006. The Company's principal products include Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), NEUPOGEN (Filgrastim), EPOGEN (Epoetin alfa) and Enbrel (etanercept). On April 1, 2006, Amgen acquired Vectibix as part of its acquisition of Abgenix, Inc. On October 24, 2006, it acquired Avidia, Inc., which discovered and developed a class of human therapeutic known as Avimer proteins. In July 2007, it acquired Alantos and Ilypsa.

Share Price: $40.11 3/20/2008
52 Week High: $69.11
52 Week Low: $39.16
EPS: $2.82
P/E Ratio: 14.22
Outstanding Shares: 1.09 Billion


AMGEN INC
1 Amgen Center Dr
Thousand Oaks, CA 91320-1799
USA
Phone: 805-447-1000
Fax: 805-447-1010
http://www.amgen.com

Daily One-Year Charts







Weekly Five-Year Charts




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMGN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AMGN News: Amgen Announces Launch Of Blood Counts™ And Collaboration With StoryCorps To Record And Share Stories Of Those Impacted By ... 12/02/2016 04:00:00 PM
AMGN News: Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimil... 12/02/2016 09:00:00 AM
AMGN News: Amgen To Present At The Citi 2016 Global Healthcare Conference 12/01/2016 04:00:00 PM
AMGN News: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patie... 11/30/2016 06:31:00 PM
AMGN News: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function in Patie... 11/30/2016 06:30:00 PM
PostSubject
#375   FDA approves AMGN’s Humira biosimilar: DewDiligence 09/23/16 07:13:48 PM
#374   AMGN---GLTA! Dadx4 09/15/16 09:57:54 AM
#373   AMGN romanov5 09/07/16 12:09:28 PM
#372   AMGN/AGN report phase-3 data for Herceptin FoB: #msg-124404733. DewDiligence 08/09/16 10:43:03 AM
#371   It's a small risk for AMGN, since the DewDiligence 08/02/16 06:26:03 PM
#370   Any thoughts on the Advaxis deal? gccarlin99 08/02/16 06:21:25 PM
#369   AMGN DAY TREND1 07/28/16 01:09:17 PM
#368   AMGN DAY TREND1 07/25/16 03:08:51 PM
#367   Short % of Float = 1.19% TREND1 07/25/16 02:42:35 PM
#366   Inst % Owned = 88% TREND1 07/25/16 02:26:16 PM
#365   EPS = 9.15 TREND1 07/25/16 02:24:56 PM
#364   AMGN DAY TREND1 07/23/16 12:22:25 PM
#363   AMGN bullish 163.03 stocktrademan 07/21/16 02:13:23 PM
#362   This Bounce Has Serious Legs: $AMGN ITMS 06/28/16 12:11:37 PM
#361   The Big Short's Dr. Michael Burry goes long 0dd Lot 05/23/16 08:42:00 PM
#360   $AMGN Daily and Weekly Charts http://www.stock $Pistol Pete$ 02/18/16 09:28:01 PM
#359   Who Would Make a Good Suitor for Shield nyctraydr 02/15/16 11:57:25 AM
#358   $AMGN Daily Chart http://www.stockcharts.com/c $Pistol Pete$ 02/14/16 05:21:11 PM
#357   Dermira Targets a Billion Dollar Opportunity -article mentions venturecapp 01/22/16 11:10:33 AM
#356   Is Guardant Next in Line for a Big trendmkr 01/08/16 11:57:24 AM
#355   Amgen is Targeting a Blockbuster SOC Upheaval in trendmkr 01/07/16 01:00:55 PM
#354   Good news for us: http://finance.yahoo.com/news/analysts-latest-recommendations- investorsa 12/29/15 09:15:05 AM
#353   thanx Dewwy Fibanotch 12/01/15 01:48:18 PM
#352   I’ve heard suggestions that AMGN might consider spinning DewDiligence 12/01/15 11:59:44 AM
#351   Do u care to elaborate on either? Fibanotch 12/01/15 11:41:16 AM
#350   Are you asking about a split-up of AMGN DewDiligence 11/30/15 07:11:35 PM
#349   u think this thing will split , in Fibanotch 11/30/15 05:55:37 PM
#348   FDA reviewing NVS’ 351(k) submission for Neulasta FoB: #msg-118583523. DewDiligence 11/18/15 10:19:21 AM
#347   Musings on Humira’s patent estate: #msg-118144295. DewDiligence 10/31/15 12:17:10 PM
#346   Bunch of BS.. If AMGN had missed by Sundance2 10/28/15 07:03:28 PM
#345   AMGN 3Q15 CC slides: DewDiligence 10/28/15 05:04:56 PM
#344   Blew every number out and AH is less Sundance2 10/28/15 04:22:14 PM
#343   Not much activity on this board. Geeez no Sundance2 10/28/15 02:30:03 PM
#342   $AMGN recent news/filings stocktrademan 07/31/15 11:31:47 AM
#341   Amgen Announces 2015 Third Quarter Dividend investorsa 07/29/15 08:46:07 AM
#340   Zarxio (Neupogen FoB) update: #msg-115571193. DewDiligence 07/21/15 12:30:03 PM
#339   Still priced low: http://247wallst.com/healthcare-business/2015/07/20/4-large-c investorsa 07/20/15 09:25:14 AM
#338   Good buying Opp today while the new drug bundyelvis 06/10/15 10:36:26 AM
#337   images.investorshub.advfn.com/images/uploads/2015/5/22/rqnjsmemorial2.jpg[/ Kristofer 05/25/15 11:36:01 AM
#336   AMGN has it's target price up to $8. V63 05/12/15 01:16:02 AM
#335   This is why you buy Nviv read and garywoodruff 05/02/15 08:23:47 AM
#334   AMGN mentioned late in the article: Robots Go Viral daMonsta 03/26/15 03:36:32 PM
#333   Yeah---- literally as of now some $50.00 more ManyYearsOTC 03/04/15 10:40:56 AM
#332   not i daMonsta 10/28/14 12:08:42 PM
#331   Anyone see AMGN partnering with EPGL for some 68113 10/22/14 08:14:58 PM
#330   I'm in!! KingDMC 10/21/14 01:57:42 PM
#329   $AMGN William Blair Reaffirms Market Perform On Amgen maytepper 08/05/14 09:55:17 AM
#328   Evolocumab is not exactly under the radar, although DewDiligence 05/02/14 06:07:21 PM
#326   Just a lil alert,, Before I begin to ManyYearsOTC 03/30/14 11:59:13 AM
#325   Amgen Announces Positive Top-Line Results From Phase 3 [SMART MONEY] 12/17/13 09:21:49 AM
PostSubject